Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
White Tetterine Miconazole Nitrate 2 g/100g Ointment, 1 tube — NDC 12258-242-01 (Billing 12258-0242-01)
by S.S.S. Company · 1 TUBE in 1 CARTON / 28.4 g in 1 TUBE
This is a package of 1 tube of White Tetterine Miconazole Nitrate 2 g/100g Ointment from S.S.S. Company, marketed since Feb 1995 and currently FDA-listed. It is this product's only package size.
NDC 12258-0242-01
🏷️ FDA NDC (as labeled)
12258-242-01
billing pads the product segment with a zero
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 12258-242-01 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 12258 labeler · 242 product · 01 package
- Package marketed since
- Feb 28, 1995
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC)
- 0312258242010
- FDA record last changed
- Jul 24, 2026
⚠️
Other active recalls for Miconazole Nitrate (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jan 10, 2024 — Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0315-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
12258-242-01
Product NDC
12258-242
11-digit billing NDC
12258024201
UNII
VW4H1CYW1K
UPC
0312258242010
Application #
M005
SPL Set ID
861895df-c989-4afd-bb31-c87c644139ef
Established class (EPC)
Azole Antifungal
Chemical class
Azoles
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
1995-02-28
Route
TOPICAL
Dosage form
OINTMENT
Substance
MICONAZOLE NITRATE
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
90154050104210
GPI class
Tetterine
Quick answers
- GPI-14 (Medi-Span): 90154050104210
- RxCUI (RxNorm): 998442
Why two NDCs?
The FDA registers this code as 12258-242-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 12258-0242-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Azole Antifungal class.
Pharmacologic class
Azole Antifungal
Drug family (ATC)
Antiinfectives and antiseptics for local oral treatment, Imidazole derivatives, Imidazole and triazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
📖 What it is MedlinePlus · NLM
Topical miconazole is used to treat tinea corporis(ringworm; fungal skin infection that causes a red scaly rash on different parts of the body), tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks), and tinea pedis (athlete's foot; fungal infection of the skin on the feet and between the toes). Miconazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection. Not all products should be used to treat all of these conditions. Please read the label for each product to select the one to treat your conditi...
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- It treats fungal and yeast infections. Depending on the product, that means vaginal yeast infections, athlete's foot, jock itch, ringworm, or thrush in the mouth and throat (Oravig...
- Apply it to your upper gum in the morning after brushing, with dry hands. Hold it in place for 30 seconds. Don't crush, chew or swallow it. Use it once a day for 14 days.
- Most are mild, like diarrhea, nausea, headache, upper belly pain or a change in taste. Vaginal products may cause mild burning or itching at first. Stop and get help for hives, tro...
- Tell me if you take warfarin. Miconazole can boost its blood-thinning effect, so watch for bleeding or bruising. With Oravig, oral diabetes medicines, phenytoin and ergot alkaloids...
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
💬 Questions about Miconazole Nitrate?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 6, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 12258-0242-01 You're viewing this Main listing | 1 TUBE in 1 CARTON / 28.4 g in 1 TUBE | 1995-02-28 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 70000-0718-01 | Cardinal | 1 tube | $0.078 | — | Availability likely | — |
| Antifungal Cream 2 g/100g 21922-0095-06 | Encube | 1 tube | $0.079 | — | Availability likely | — |
| MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 00536-1375-75 | Rugby | 1 tube | $0.121 | — | Availability likely | — |
| Critic Aid Clear AF 20 mg/g 11701-0067-14 | Coloplast | 142 g | — | — | FDA listed | — |
| Green Tetterine 2 g/100g 12258-0241-01 | S.S.S. | 1 can | — | — | FDA listed | — |
| White Tetterine 2 g/100gthis 12258-0242-01 | S.S.S. | 1 tube | — | — | FDA listed | — |
| Triple Antifungal 2 g/100g 16864-0040-02 | Advantice | 1 tube | — | — | FDA listed | — |
| Medline 2 g/100g 53329-0172-10 | Medline | 71 g | — | — | FDA listed | — |
| Antifungal 2 g/100g 84722-3060-00 | VIVE | 1 g | — | — | FDA listed | — |
| MacerRx Web 2 g/100g 44577-0205-56 | Clinical | 1 tube | — | — | FDA listed | — |
| Nedtol Folliculitis Treatment Creams 2 g/100g 84867-0022-01 | Jiashen | 120 g | — | — | FDA listed | — |
| Miconazole Cream 2 g/100g 87236-0013-04 | Aldermed | 113 g | — | — | FDA listed | — |
| Lasolex AG 2 g/100g 59088-0207-07 | Puretek | 85 g | — | — | FDA listed | — |
| Kerova Miconazole Nitrate 2 g/100g 85959-0001-01 | Guangzhou | 100 g | — | — | FDA listed | — |
| Femmesil Maximum Strength 2 g/100g 24909-0202-28 | Aidance | 1 bottle | — | — | Discontinued | — |
| BOA VIDA Antifungal 2 g/100g 62654-0147-01 | Central | 113 g | — | — | FDA listed | — |
| MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 68788-8845-03 | Preferred | 1 tube | — | — | FDA listed | — |
| MICONAZOLE Nitrate 2% 2 g/100g 71399-0071-01 | Akron | 1 tube | — | — | FDA listed | — |
| MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 68788-8895-03 | Preferred | 1 tube | — | — | FDA listed | — |
| Doctor Jiao Antifungal Cream 2 g/100g 87537-0002-02 | Jiangxi | 1 tube | — | — | FDA listed | — |
| MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 77338-0041-25 | ASTONEA | 113 g | — | — | FDA listed | — |
| Remedy Antifungal With Olivamine 2 g/100g 53329-0162-04 | Medline | 113 g | — | — | Discontinued | — |
| MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 69396-0014-05 | Trifecta | 15 g | — | — | FDA listed | — |
| FifthPulse Miconazole Nitrate Cream 4oz 2 g/100g 69571-0017-01 | Front | 113.4 g | — | — | FDA listed | — |
| Antifungal 2 g/100g 67777-0710-02 | Dynarex | 144 packets | — | — | FDA listed | — |
| MICONAZOLE Nitrate 2 g/100g 68071-3429-03 | NuCare | 1 tube | — | — | FDA listed | — |
| PiYanPing Antifungal 2 g/100g 69070-0304-01 | Zhejiang | 1 tube | — | — | FDA listed | — |
| MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 69771-0041-25 | GERI-GENTLE | 113 g | — | — | FDA listed | — |
| Claravie 2 g/100g 61554-0305-11 | Gentell | 113 g | — | — | FDA listed | — |
| MOROVANJock Itch Antifungal 2 g/100g 87800-0006-01 | HONG | 100 g | — | — | FDA listed | — |
| Hermon Jock Itch Ringworm Athletes Foot Cream 2 g/100g 85398-0036-01 | Beautivity | 100 g | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
1995
On the market since
Feb 1995
📍
2026
Currently FDA-listed
31 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Miconazole inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII I9PJ0O6294
A modified starch derived from corn or potato starch with aluminum salt and octenylsuccinic acid added. It acts as a binder to hold tablet ingredients together and as a thickening agent in liquid formulations.
-
UNII I9O0E3H2ZE
Paraffin is a waxy, petroleum-derived substance used as a coating, lubricant, and hardening agent in tablets and capsules. It helps protect the medicine from moisture and gives pills a smooth finish.
-
UNII 4T6H12BN9U
Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.
3 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesFragrance, paraffin wax, petrolatum, and starch
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerS.S.S. Company
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code12258
First marketedFeb 1995
Product typeHuman Otc Drug
Portfolio4 products on file
More NDCs from S.S.S. Company labeler code 12258
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 When Using This Product
📄 Stop Use and Ask a Doctor If
📄 Keep Out of Reach of Children
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses treats most athlete's foot, jock itch and ringworm. Relieves itching, scaling, cracking, burning, redness, soreness, irritation, discomfort, and chafing associated with jock itch. Relieves itchy, scaly skin between the toes or itching, burning feet associated with athlete's foot Ask your health professional regarding additional uses
⏱️ Dosage and Administration ▾
Directions Clean the affected area and dry thoroughly. Apply a thin layer of the product over the affected area twice daily (morning and night) or as directed by a doctor. Supervise children in the use of this product.
For athlete's foot pay special attention to the spaces between the toes, wear well fitting ventilated shoes, and change shoes and socks at least once daily. For athlete's foot and ringworm use daily for 4 weeks. For jock itch, use daily for 2 weeks.
If condition persists longer consult a doctor. This product is not effective on the scalp or nails.
⚠️ Warnings ▾
Warnings Do not use on children under 2 years of age unless directed by a doctor Do not use on diaper rash For external use only Stop use and ask a doctor if for athlete's foot and ringworm, irritation occurs or if there is no improvement within 4 weeks for jock itch if irritation occurs of if there is no improvement with-in 2 weeks When using this product Avoid contact with eyes KEEP OUT OF REACH OF CHILDREN If swallowed, get medical help or contact a Poison Control Center right away
🧪 Active Ingredient ▾
Active Ingredient: Miconazole Nitrate 2%
🧪 Inactive Ingredients ▾
Other Ingredients Fragrance, paraffin wax, petrolatum, and starch
🎯 Purpose ▾
Purpose: Antifungal
📄 Do Not Use ▾
Do not use on children under 2 years of age unless directed by a doctor Do not use on diaper rash For external use only
📄 When Using This Product ▾
When using this product Avoid contact with eyes
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if for athlete's foot and ringworm, irritation occurs or if there is no improvement within 4 weeks for jock itch if irritation occurs of if there is no improvement with-in 2 weeks
📄 Keep Out of Reach of Children ▾
KEEP OUT OF REACH OF CHILDREN If swallowed, get medical help or contact a Poison Control Center right away
📄 Package Label / Principal Display Panel ▾
Principal Display Panel NDC 12258-242-01 Tetterine® OINTMENT Antifungal Cures: Athlete's Foot, Jock Itch and Ringworm Net wt. 1oz. (28.4 g.) Other Packaging Content S.S.S. Company Atlanta, GA 30315 MADE IN U.S.A. Manufactured by S.S.S. Company Atlanta, GA See our online catalog at www.ssspharmaceuticals.com Rev. B Principal Display Panel
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Miconazole 3 (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Miconazole 3. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$35.6K
Claims incl. refills
725
Beneficiaries
649
Spend / beneficiary
$54.91
Spend / claim
$49.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for White Tetterine (this brand).
Top reported reactions
Reporter sex
Male · 24%
Female · 76%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by S.S.S. Company. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
S.S.S. Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.